Simioni Christiane, Sanchez Oliveira Rita de Cassia, Moscovi Thomas, D' Agostini Deutsch Alice, Cordioli Eduardo, Santos Erica
Hospital Israelita Albert Einstein, Maternal and Fetal Medicine Department, São Paulo, Brazil.
J Matern Fetal Neonatal Med. 2013 Apr;26(6):622-4. doi: 10.3109/14767058.2012.745503. Epub 2012 Nov 28.
Primary cytomegalovirus (CMV) infection during pregnancy is the leading infectious cause of congenital neurological disabilities. Diagnosis of maternal primary CMV infection and fetal compromise can be difficult, as well as the fact that most infected child are asymptomatic at birth, which makes binomial CMV and pregnancy challenging. The treatment of pregnant women with CMV hyperimmunoglobulin (CMV-HIG) has shown promising results. However, as far as we know, no randomized trials of immunoglobulin therapy of CMV-infected fetuses are ongoing. We describe CMV-HIG administration for twin pregnancy as maternal and fetal infection early in gestation. The epidemiology, clinical manifestations, prevention strategies and treatment of CMV infections are reviewed.
孕期原发性巨细胞病毒(CMV)感染是先天性神经残疾的主要感染原因。诊断孕妇原发性CMV感染和胎儿受累可能很困难,而且大多数受感染儿童出生时无症状,这使得CMV与妊娠的关系颇具挑战性。用巨细胞病毒高免疫球蛋白(CMV-HIG)治疗孕妇已显示出有希望的结果。然而,据我们所知,目前尚无针对CMV感染胎儿进行免疫球蛋白治疗的随机试验。我们描述了在妊娠早期将CMV-HIG用于双胎妊娠的母婴感染情况。本文还对CMV感染的流行病学、临床表现、预防策略及治疗进行了综述。